These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 25553695)

  • 1. Formulation and evaluation of mini-tablets-filled-pulsincap delivery of lornoxicam in the chronotherapeutic treatment of rheumatoid arthritis.
    Hadi MA; Rao NG; Rao AS
    Pak J Pharm Sci; 2015 Jan; 28(1):185-93. PubMed ID: 25553695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution enhancement and formulation of rapid-release lornoxicam mini-tablets.
    Tawfeek HM; Saleem IY; Roberts M
    J Pharm Sci; 2014 Aug; 103(8):2470-83. PubMed ID: 24995853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix-mini-tablets of lornoxicam for targeting early morning peak symptoms of rheumatoid arthritis.
    Mohd AH; Raghavendra Rao NG; Avanapu SR
    Iran J Basic Med Sci; 2014 May; 17(5):357-69. PubMed ID: 24967065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of ileo-colonic targeted matrix-mini-tablets of Naproxen for chronotherapeutic treatment of rheumatoid arthritis.
    Hadi MA; Raghavendra Rao NG; Srinivasa Rao A
    Saudi Pharm J; 2016 Jan; 24(1):64-73. PubMed ID: 26903770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and in vitro characterization of buccoadhesive tablets of timolol maleate.
    Gaikwad SS; Thombre SK; Kale YK; Gondkar SB; Darekar AB
    Drug Dev Ind Pharm; 2014 May; 40(5):680-90. PubMed ID: 24592893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigations.
    Hamza Yel-S; Aburahma MH
    Drug Dev Ind Pharm; 2010 Mar; 36(3):337-49. PubMed ID: 19722915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel sustained-release fast-disintegrating multi-unit compressed tablets of lornoxicam containing Eudragit RS coated chitosan-alginate beads.
    Aburahma MH; Hamza Yel-S
    Pharm Dev Technol; 2011 Aug; 16(4):316-30. PubMed ID: 20307250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro and in vivo investigation into the suitability of compression coated tablets of indomethacin for the treatment of rheumatoid arthritis which follow circadian rhythms.
    Songa AS; Meka VS; Nali SR; Kolapalli VR
    Drug Dev Ind Pharm; 2013 Mar; 39(3):447-56. PubMed ID: 22380574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation development and statistical optimization of chronotherapeutic tablets of indometacin.
    Tinny T; Chacko AJ; Jose S
    Drug Dev Ind Pharm; 2013 Sep; 39(9):1357-63. PubMed ID: 22931205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a matrix tablet prepared with polyacrylamide-g-sodium alginate co-polymers and their partially hydrolyzed co-polymers for sustained release of diltiazem hydrochloride.
    Mandal S; Ray R; Basu SK; Sa B
    J Biomater Sci Polym Ed; 2010; 21(13):1799-814. PubMed ID: 20557689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation and Optimization of the Effect of Polymers on Drug Release of Norfloxacin from Floating Tablets.
    Gadade DD; Sarda K; Shahi SR
    Polim Med; 2016; 46(2):117-127. PubMed ID: 28397452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation.
    Chawla A; Sharma P; Pawar P
    Acta Pharm; 2012 Dec; 62(4):529-45. PubMed ID: 23333888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and pharmacokinetic evaluation of alginate-pectin polymeric rafts forming tablets using box behnken design.
    Abbas G; Hanif M
    Drug Dev Ind Pharm; 2018 Dec; 44(12):2026-2037. PubMed ID: 30084289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of press coated tablets for pulsatile drug delivery using hydrophilic and hydrophobic polymers.
    Rane AB; Gattani SG; Kadam VD; Tekade AR
    Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1213-7. PubMed ID: 19881269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cellulose derivative and ethylene glycol on optimization of lornoxicam transdermal formulation.
    Shahzad Y; Khan Q; Hussain T; Shah SN
    Int J Biol Macromol; 2013 Oct; 61():26-32. PubMed ID: 23827761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pharmaceutical study on lornoxicam fast disintegrating tablets: formulation and in vitro and in vivo evaluation.
    Moutasim MY; ElMeshad AN; El-Nabarawi MA
    Drug Deliv Transl Res; 2017 Jun; 7(3):450-459. PubMed ID: 28283842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified pulsincap of ibuprofen--a novel approach for chronotherapy.
    Yalavarthi PR; Vulava J; Vadlamudi HC; Balambhaigari RY; Nair R
    Curr Drug Deliv; 2013 Jun; 10(3):299-308. PubMed ID: 23445502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology.
    Huang YB; Tsai YH; Lee SH; Chang JS; Wu PC
    Int J Pharm; 2005 Jan; 289(1-2):87-95. PubMed ID: 15652202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once daily bioadhesive vaginal clotrimazole tablets: design and evaluation.
    Sharma G; Jain S; Tiwary AK; Kaur G
    Acta Pharm; 2006 Sep; 56(3):337-45. PubMed ID: 19831282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.